mal dose of 960 mg daily for the treatment of adenocarci-seen in the future as the life-spans of patients with HIV infection, and therefore the duration of therapy, continue to lengthen. noma of the uterus [9].
No takes yet. Share an insight, caveat, or question.
Striker et al. (1998) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: